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Abstract
In the past three years, several psychosocial treatments for borderline personality disorder have
received empirical support. This review highlights findings from recent treatment studies and
discusses how these findings have dramatically altered clinical practice for this disorder.
Introduction and context
Historically, borderline personality disorder (BPD) was
viewed as a challenging and pervasive mental health
disorder that was largely non-responsive to treatment
[1]. Given that evidence-based treatments were not
available and the fact that many clinicians held
pessimistic views about people with the illness, diagnosis
of the disorder was typically avoided. Consequently,
persons with BPD did not receive adequate care and
often experienced mistreatment by health care providers
[1,2]. Over the past two decades, a growing body of
evidence from treatment studies has dramatically altered
views about the disorder. Positive results from treatment
studies have also facilitated a shift in attitudes and
practices for persons with BPD.
Recent advances
Extensive research findings support the use of a variety of
clinical approaches for BPD ranging in theoretical
orientation (for example, behaviour therapy, cognitive
interventions, or psychodynamic approaches), duration
(for example, 12 months or 20 weeks), and application
(for example, inpatient, adjunctive treatments, or
comorbid-specific). In addition, there are now studies
that provide important information regarding the cost-
effectiveness and long-term clinical outcomes associated
with these interventions. The shift toward a more
optimistic and compassionate attitude toward indivi-
duals with BPD stems largely from a growing body of
empirical evidence in support of various approaches.
Cognitive behavioural interventions have received the
most empirical support, with dialectical behaviour
therapy (DBT) being the most extensively studied and
disseminated approach [2,3]. Nine published trials
demonstrate that DBT is associated with a significant
decrease in the frequency and medical severity of suicidal
and self-injurious behaviour, the number of inpatient
psychiatric days, and reliance on psychotropic medica-
tions [4-12]. Also, trials examining adaptations of DBT
across clinical settings and comorbid groups are promis-
ing, particularly among inpatient populations [13],
adolescents [14], and those with eating disorders [15]
and substance abuse [7,9,11].
Despite these impressive results, the standard DBT
model (for example, 12 months of weekly individual
therapy, skills training, phone skills coaching, and a
therapist consultation team) is considered to be a
resource-intensive treatment that requires substantial
therapist training and involvement [1,16]. Unfortu-
nately, most clinical settings lack the resources to apply
the comprehensive package and/or train staff accord-
ingly. Given these considerations, there is growing
interest in developing and evaluating alternative ther-
apeutic approaches for BPD. For example, alternative
cognitive behaviour therapy (CBT)-based approaches,
including schema-focused therapy (SFT), have received
preliminary empirical support for the treatment of BPD.
Although there have been critiques of this study [17], SFT
was associated with greater treatment retention and
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controlled multi-site clinical trial compared with trans-
ference-focused psychotherapy (TFP) [18]. The cost-
effectiveness of these two treatments has also been
examined, with SFT showing economic advantage over
TFP [19]. A large multi-site study comparing 1 year of
CBT plus treatment as usual (TAU) to TAU alone for
individuals with BPD demonstrated that CBT was
associated with superior treatment gains (for example,
fewer suicidal behaviours), less symptom distress (for
example, a reduction in anxiety and dysfunctional
beliefs), and greater cost-effectiveness [20,21].
Interest in the feasibility and cost-effectiveness of the
CBT-based STEPPS (Systems Training for Emotional
Predictability and Problem Solving) program [22]
continues to grow. Designed as an adjunct to ongoing
clinical care, STEPPS is a 20-week manualized group
intervention for outpatients meeting diagnostic criteria
for BPD. Uncontrolled studies [23,24] and a recent
randomized trial [25] have shown that STEPPS is
associated with significant improvements across cogni-
tive, emotional, and interpersonal domains. Compared
with a control condition, participants exposed to STEPPS
reported less impulsivity, a reduction in negative
thoughts and feelings, and fewer emergency room
admissions. Further support for STEPPS comes from a
recently published uncontrolled pilot study in which
STEPPS was administered in a forensic setting to 12
female offenders with BPD [26]. Participants reported
less distress from BPD-related symptoms and improve-
ments on negative affect and depression.
Additionally, there is growing evidence to support the
clinical value of other, brief, skills-based group interven-
tions (typically offered to supplement ongoing or
standard care) in the treatment of BPD. Time-limited
psychotherapy groups focusing on skill acquisition and
adaptive functioning are among the most recognized
treatment developments for BPD in recent years. DBT-
informed skills training groups, delivered without
standard DBT individual therapy, have been studied in
several trials and have been shown to be associated with
significantly fewer suicidal acts, self-injurious beha-
viours, and other impulsive self-destructive tendencies
(for example, substance abuse, binge eating, and angry
outbursts) in patients with BPD [27-29]. Likewise, a six-
session manual-assisted cognitive therapy (MACT) inter-
vention was associated with decreases in the frequency of
self-injurious behaviours with treatment gains main-
tained at 6-month follow-up [30]. Gratz and Gunderson
[31] evaluated the clinical effectiveness of a 14-week
emotion regulation skills group for the treatment of self-
injurious behaviour in women with BPD. The emotion
regulation group incorporated elements from DBT,
acceptance and commitment therapy, and emotion-
focused therapy, and focused on increasing emotional
awareness, decreasing experiential avoidance, and teach-
ing adaptive coping skills. Participants were randomly
assigned to receive either the skills group in addition to
current treatment or current treatment only. The treat-
ment group showed significant reductions in self-
injurious behaviour and improvements on measures of
depression and anxiety, and demonstrated better ability
to cope with negative emotions. Finally, education about
their diagnosis can also be beneficial to patients
diagnosed with BPD. A randomized trial by Zanarini
and Frankenburg [32] demonstrated that individuals
who were educated about the diagnosis of BPD in a
psychoeducation workshop yielded significant improve-
ments in general impulsivity and relational difficulties.
Recently, interest in the evaluation of psychodynamic
treatments for BPD has emerged with several dynami-
cally informed approaches demonstrating effectiveness
with persons with BPD. TFP, studied in a randomized
controlled trial, was compared with DBT and supportive
treatment [33]. The three treatments showed comparable
reductions on measures of depression, anxiety, and
impulsivity, with the TFP and DBT groups showing the
greatest reductions in suicidality. Mentalization-based
day treatment (MBT) has also been studied and
empirically supported in randomized controlled trials
[34,35], and a recent follow-up study [36] demonstrated
superior maintenance of treatment gains among those
who received MBT. Compared with a control group,
those assigned to MBT reported fewer suicide attempts, a
reduced number of hospital and emergency room visits,
a decreased use of psychotropic medications, and greater
global functioning 5 years post-treatment. Thus, psycho-
dynamic approaches continue to be among the forefront
of innovative and efficacious treatments for BPD.
Efforts to evaluate potential mechanisms and moderaters
of change across treatment approaches have also received
increased attention in recent years. For instance,
researchers have demonstrated the importance of
attachment and reflective functioning in TFP [37] and
the role of enhanced self-concept and self-affirmation
in DBT [38].
Implications for clinical practice
The rapid and growing interest in developing and
evaluating clinical interventions for a population once
viewed with reluctance reflects the changing and
increasing optimism about this disorder. The growing
empirical evidence for the efficacy of various treatment
approaches for BPD indicates that it would be
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facilitate the assessment and diagnosis of BPD. More-
over, with a greater availability of evidence-based
treatments for BPD, potentially more individuals with
the disorder will receive empirically supported treatment
for their symptoms. Importantly, given that multiple
structured approaches are associated with positive
clinical changes in BPD, future research establishing
mechanisms of change and long-term functioning will
be essential [39,40]. For example, specific treatment
approaches may be more effective with certain patient
subgroups and/or levels of motivation for change [41].
While there is evidence for the economic benefit of using
several longer-term psychotherapies (for example, DBT,
SFT, or TFP), the support for time-limited group
therapies is equally salient given the need to develop
efficacious interventions that are more easily transpor-
table and cost-effective. A number of treatments for BPD
are now manualized to facilitate greater dissemination
and easier implementation across clinical settings.
Finally, in light of the emerging cost-effectiveness data
and the consistent finding that several treatments are
associated with decreased pain and suffering among
those with BPD, these data have important implications
for the provision of health care and medical insurance
coverage.
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